{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:43:30Z","timestamp":1791996210580,"version":"4.4.0"},"reference-count":233,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    In spite of an increasing array of investigations, the relationships between viral infections and allogeneic hematopoietic stem cell transplantation (HSCT) are still controversial, and almost exclusively regard DNA viruses. Viral infections\n                    <jats:italic>per se<\/jats:italic>\n                    account for a considerable risk of morbidity and mortality among HSCT recipients, and available antiviral agents have proven to be of limited effectiveness. Therefore, an optimal management of viral infection represents a key point in HSCT strategies. On the other hand, viruses bear the potential of shaping immunologic recovery after HSCT, possibly interfering with control of the underlying disease and graft-\n                    <jats:italic>versus<\/jats:italic>\n                    -host disease (GvHD), and eventually with HSCT outcome. Moreover, preliminary data are available about the possible role of some virome components as markers of immunologic recovery after HSCT. Lastly, HSCT may exert an immunotherapeutic effect against some viral infections, notably HIV and HTLV-1, and has been considered as an eradicating approach in these indications.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2020.569381","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:45:22Z","timestamp":1611103522000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications"],"prefix":"10.3389","volume":"11","author":[{"given":"Claudio","family":"Annaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Serpenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Saporiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Galassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grifoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Goldaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Onida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1999.tb02416.x","article-title":"PCR-RFLP analysis of cytomegalovirus infections associated with bone marrow transplantation in Japanese children","volume":"43","author":"Kawasaki","year":"1999","journal-title":"Microbiol Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: An EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01186","article-title":"Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients","volume":"10","author":"Stern","year":"2019","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24775","article-title":"Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients","volume":"89","author":"Ishii","year":"2017","journal-title":"J Med Virol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050248","article-title":"Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation","volume":"7","author":"Borchers","year":"2012","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw064","article-title":"Utility of the enzyme-linked immunospot interferon-\u03b3- release assay to predict the risk of cytomegalovirus infection in hematopoietic cell transplant recipients","volume":"213","author":"Nesher","year":"2016","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1232","article-title":"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.10.3830","article-title":"Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation","volume":"99","author":"Hebart","year":"2002","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704442","article-title":"Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen","volume":"33","author":"Mohty","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05800.x","article-title":"Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-\u03b3-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cel","volume":"131","author":"Ohnishi","year":"2005","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11912","article-title":"Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection","volume":"93","author":"Lilleri","year":"2008","journal-title":"Haematologica"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-273508","article-title":"Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study","volume":"116","author":"Gratama","year":"2010","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.330","article-title":"Reconstitution of CMV pp65 and IE-1-specific IFN-\u03b3 CD8+ and CD4 + T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT","volume":"46","author":"Tormo","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00626.x","article-title":"Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Borchers","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041648","article-title":"Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Lilleri","year":"2012","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074744","article-title":"Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV\u00ae assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications","volume":"8","author":"Tey","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix192","article-title":"Identifying cytomegalovirus complications using the quantiferon-CMV assay after allogeneic hematopoietic stem cell transplantation","volume":"215","author":"Yong","year":"2017","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.01.002","article-title":"Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR","author":"Krawczyk","year":"2018","journal-title":"J Clin Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13220","article-title":"Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients","volume":"22","author":"Paouri","year":"2018","journal-title":"Pediatr Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2446-4","article-title":"Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation","volume":"94","author":"Kato","year":"2015","journal-title":"Ann Hematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbmt.2005.07.008","article-title":"Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection","volume":"11","author":"Gallez-Hawkins","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12540","article-title":"Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs","volume":"18","author":"Nemeckova","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/347213","article-title":"Clinical factors influencing phenotype of HCMV-specific CD8+ T cells and HCMV-induced interferon-gamma production after allogeneic stem cells transplantation","volume":"2013","author":"Gayoso","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.03.027","article-title":"Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation","volume":"23","author":"Ogonek","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21367","article-title":"Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8+ T cells by flow cytometry","volume":"92","author":"Ci\u00e1urriz","year":"2017","journal-title":"Cytom Part B - Clin Cytom"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.04109","article-title":"Reconstitution of HLA-A*2402 - Restricted cytomegalovirus-specific T-cells following stem cell transplantation","volume":"80","author":"Gondo","year":"2004","journal-title":"Int J Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.172","article-title":"Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN CD8 and CD4 T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients","volume":"45","author":"Tormo","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00888","article-title":"The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation","volume":"9","author":"Grosso","year":"2019","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.9.5226-5240.2003","article-title":"Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers","volume":"77","author":"Elkington","year":"2003","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01262-06","article-title":"The Cytomegalovirus-Specific CD4+ T-Cell Response Expands with Age and Markedly Alters the CD4+ T-Cell Repertoire","volume":"81","author":"Pourgheysari","year":"2007","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1124","article-title":"Immunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors","volume":"9","author":"Lee","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1387","article-title":"Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells","volume":"100","author":"\u00d6zdemir","year":"2002","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/648423","article-title":"Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)\u2013Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients","volume":"49","author":"Barron","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-878918","article-title":"Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation","volume":"133","author":"Camargo","year":"2019","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703351","article-title":"Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin","volume":"29","author":"Nakai","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21727","article-title":"Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using the quantiFERON\u00ae-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital","volume":"82","author":"Fleming","year":"2010","journal-title":"J Med Virol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbmt.2009.02.009","article-title":"Effect of Conditioning Regimen Intensity on CMV Infection in Allogeneic Hematopoietic Cell Transplantation","volume":"15","author":"Nakamae","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1046\/j.1365-2141.2003.04671.x","article-title":"Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation","volume":"90","author":"Junghanss","year":"2003","journal-title":"Br J Haematol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00706.x","article-title":"A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: Reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group","volume":"14","author":"George","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.3390\/ijms21103663","article-title":"Delayed nk cell reconstitution and reduced nk activity increased the risks of cmv disease in allogeneic-hematopoietic stem cell transplantation","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.09.003","article-title":"HLA-DRB1*09 Is Associated with Increased Incidence of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"13","author":"Du","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B48","first-page":"7","article-title":"Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype","volume":"9","author":"Sobecks","year":"2011","journal-title":"Exp Clin Transplant"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nri3904","article-title":"gammadelta T cells in cancer","volume":"15","author":"Silva-Santos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000682","article-title":"Impact of gd T cells on clinical outcome of hematopoietic stem cell transplantation: Systematic review and meta-analysis","volume":"3","author":"Arruda","year":"2019","journal-title":"Blood Adv"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.12.558","article-title":"NOD2\/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C\u2265T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Jaskula","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.166","article-title":"Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors","volume":"46","author":"Elmaagacli","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2015.12.022","article-title":"Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients","volume":"31","author":"Piao","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00109","article-title":"Donor genotype in the Interleukin-7 receptor \u03b1-chain predicts risk of graft-versus-host disease and cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Kielsen","year":"2018","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12163","article-title":"Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant","volume":"16","author":"Taimur","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.02.004","article-title":"Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation","volume":"13","author":"Micklethwaite","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"B58","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13045-017-0469-0","article-title":"Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I\/II multicenter clinical trial","volume":"10","author":"Qian","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1086\/587749","article-title":"Multimer Staining of Cytomegalovirus Phosphoprotein 65\u2013Specific T Cells for Diagnosis and Therapeutic Purposes: A Comparative Study","volume":"46","author":"Yao","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.11.007","article-title":"Multimer monitoring of CMV-specific T cells in research and in clinical applications","volume":"78","author":"Borchers","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208863200","article-title":"Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis","volume":"278","author":"Guillaume","year":"2003","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2007.01.001","article-title":"Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens","volume":"320","author":"Neudorfer","year":"2007","journal-title":"J Immunol Methods"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.12.007","article-title":"Functionally Active HIV-Specific T Cells that Target Gag and Nef Can Be Expanded from Virus-Na\u00efve Donors and Target a Range of Viral Epitopes: Implications for a Cure Strategy after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"22","author":"Patel","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16053","article-title":"T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy","volume":"187","author":"Keller","year":"2019","journal-title":"Br J Haematol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0824","article-title":"Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles","volume":"103","author":"Kondo","year":"2004","journal-title":"Blood"},{"key":"B73","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume-title":"Blood","author":"Feuchtinger","year":"2010"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90599","article-title":"Immunotherapy for transplantation-associated viral infections","volume":"127","author":"Roddie","year":"2017","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.232","article-title":"Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT","volume":"53","author":"Qian","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1149","article-title":"Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV-specific T cells","volume":"9","author":"McGuire","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00138","article-title":"Cytomegalovirus-Associated Inhibition of Hematopoiesis Is Preventable by Cytoimmunotherapy With Antiviral CD8 T Cells","volume":"10","author":"Renzaho","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-664755","article-title":"TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells","volume":"126","author":"Menger","year":"2015","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001977","article-title":"Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells","volume":"4","author":"Basar","year":"2020","journal-title":"Blood Adv"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-228387","article-title":"Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease","volume":"114","author":"Brewin","year":"2009","journal-title":"Blood"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902233","article-title":"CMV-Specific TCR-Transgenic T Cells for Immunotherapy","volume":"183","author":"Schub","year":"2009","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: A randomised, double-blind, placebo-controlled, phase 2 trial","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12967-015-0599-5","article-title":"Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation","volume":"13","author":"Sundarasetty","year":"2015","journal-title":"J Transl Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2352-3026(15)00246-X","article-title":"Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: Randomised phase 1b trial","volume":"3","author":"Nakamura","year":"2016","journal-title":"Lancet Haematol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2110-3","article-title":"Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial","volume":"105","author":"Mori","year":"2017","journal-title":"Int J Hematol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18301","article-title":"Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses","volume":"7","author":"Schmitt","year":"2017","journal-title":"Theranostics"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.325","article-title":"Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years\u2019 experience in a single institute","volume":"43","author":"Hou","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702770","article-title":"Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation","volume":"27","author":"Haut","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transplant"},{"key":"B92","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/cancers12020328","article-title":"Epstein-barr virus-associated post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation: Pathogenesis, risk factors and clinical outcomes","volume":"12","author":"Fujimoto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.087338","article-title":"Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation","volume":"99","author":"Uhlin","year":"2014","journal-title":"Haematologica"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.117","article-title":"Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: A Eurocord and Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle-Therapie Cellulaire collaborative study","volume":"48","author":"Dumas","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/bbmt.2002.v8.pm11846351","article-title":"Diagnosis and treatment of posttransplantation lymphoproliferative disease after hemopietic stem cell transplantation","volume":"8","author":"Wagner","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2018.11.002","article-title":"Epstein-Barr viremia and post-transplant lymphoproliferative disorders in patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide","volume":"12","author":"Mohyuddin","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000208","article-title":"Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting V\u03b42+ T cells activities after hematopoietic transplantation for blood malignancies","volume":"8","author":"Liu","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.026","article-title":"Targeted activation of human v\u03b39v\u03b42-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease","volume":"26","author":"Xiang","year":"2014","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15037","article-title":"Inverse correlation of V\u03b42+ T-cell recovery with EBV reactivation after haematopoietic stem cell transplantation","volume":"180","author":"Liu","year":"2018","journal-title":"Br J Haematol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720910964","article-title":"Management of Epstein\u2013Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Liu","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05875.x","article-title":"The presence of IFNG 3\/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation","volume":"132","author":"Bogunia-Kubik","year":"2006","journal-title":"Br J Haematol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705703","article-title":"The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation","volume":"40","author":"Bogunia-Kubik","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.351-358.2002","article-title":"Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease","volume":"40","author":"G\u00e4rtner","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3689","article-title":"Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation","volume":"102","author":"Gandhi","year":"2003","journal-title":"Blood"},{"key":"B106","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/01.TP.0000093997.83754.2B","article-title":"Epstein-Barr Virus (EBV) reactivation in allogeneic stem-cell transplantation: Relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy","volume":"77","author":"Clave","year":"2004","journal-title":"Transplantation"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V102.3.839","article-title":"Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation","volume":"102","author":"Chakrabarti","year":"2003","journal-title":"Blood"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000083","article-title":"Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant","volume":"21","author":"Rouce","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV + lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1089\/15258160260194811","article-title":"Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion","volume":"11","author":"Carlens","year":"2002","journal-title":"J Hematotherapy Stem Cell Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-242263","article-title":"Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation","volume":"115","author":"Micklethwaite","year":"2010","journal-title":"Blood"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-430413","article-title":"Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation","volume":"121","author":"Gerdemann","year":"2013","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12967-014-0336-5","article-title":"Rapid generation of clinical-grade antiviral T cells: Selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells","volume":"12","author":"Tischer","year":"2014","journal-title":"J Transl Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.262","article-title":"Viral-specific adoptive immunotherapy after allo-SCT: The role of multimer-based selection strategies","volume":"48","author":"Ram\u00edrez","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-230482","article-title":"Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)","volume":"114","author":"De Angelis","year":"2009","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2018.04.005","article-title":"Epstein-Barr virus\u2013specific cytokine-induced killer cells for treatment of Epstein-Barr virus\u2013related malignant lymphoma","volume":"20","author":"Pfeffermann","year":"2018","journal-title":"Cytotherapy"},{"key":"B121","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.bmt.1705003","article-title":"Adenovirus infection in paediatric stem cell transplant recipients: Increased risk in young children with a delayed immune recovery","volume":"36","author":"van Tol","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05331.x","article-title":"Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation","volume":"128","author":"Feuchtinger","year":"2005","journal-title":"Br J Haematol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.86","article-title":"Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: Incidence and outcome","volume":"46","author":"\u00d6hrmalm","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.09.010","article-title":"Quantitative and Qualitative CD4 T Cell Immune Responses Related to Adenovirus DNAemia in Hematopoietic Stem Cell Transplantation","volume":"17","author":"Gu\u00e9rin-El Khourouj","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2015.07.005","article-title":"Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059592","article-title":"Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application","volume":"8","author":"Geyeregger","year":"2013","journal-title":"PloS One"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109944","article-title":"Human adenovirus-specific \u03b3\/\u03b4 and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation","volume":"9","author":"D\u00f6rrie","year":"2014","journal-title":"PloS One"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181cc263b","article-title":"Rapid generation of full clinical-grade human antiadenovirus cytotoxic t cells for adoptive immunotherapy","volume":"33","author":"A\u00efssi-Rothe","year":"2010","journal-title":"J Immunother"},{"key":"B129","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/14653249.2011.636963","article-title":"Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant","volume":"14","author":"Sili","year":"2012","journal-title":"Cytotherapy"},{"key":"B130","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/CJI.0000000000000105","article-title":"Adenovirus-specific T-cell Subsets in Human Peripheral Blood and after IFN-\u03b3 Immunomagnetic Selection","volume":"39","author":"Qian","year":"2016","journal-title":"J Immunother"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2018.03.040","article-title":"Multicenter phase 1\/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation","volume":"20","author":"Ip","year":"2018","journal-title":"Cytotherapy"},{"key":"B132","article-title":"Human herpes virus-6 following pediatric allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Shachor-Meyouhas","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.09.039","article-title":"HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns","volume":"72","author":"Quintela","year":"2016","journal-title":"J Infect"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.05.019","article-title":"Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults","volume":"93","author":"Illiaquer","year":"2017","journal-title":"J Clin Virol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006991","article-title":"Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B","volume":"14","author":"Martin","year":"2018","journal-title":"PloS Pathog"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12342","article-title":"Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen","volume":"28","author":"Yamamoto","year":"2014","journal-title":"Clin Transplant"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.266","article-title":"High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: A prospective and quantitative analysis","volume":"43","author":"Wong","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001120","article-title":"BK virus\u2013specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation","volume":"4","author":"Espada","year":"2020","journal-title":"Blood Adv"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12848","article-title":"BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation","volume":"98","author":"Pello","year":"2017","journal-title":"Eur J Haematol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1182\/blood.V128.22.504.504","article-title":"Efficacy of third party BK virus (BKV) specific cytotoxic T-lymphocytes generated by ex vivo expansion for the treatment of BKV infection in stem cell transplant recipients, a phase 2 trial","volume":"128","author":"Olson","year":"2016","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.03.018","article-title":"Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Selective Control of JC Virus Reactivation","volume":"20","author":"Tan","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.221","article-title":"Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient","volume":"46","author":"Balduzzi","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7765","article-title":"A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology","volume":"241","author":"Nishizawa","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.08.036","article-title":"Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9","volume":"394","author":"Rocchi","year":"2009","journal-title":"Virology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00705-015-2363-9","article-title":"Human anelloviruses: an update of molecular, epidemiological and clinical aspects","volume":"160","author":"Spandole","year":"2015","journal-title":"Arch Virol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.04.007","article-title":"Torquetenovirus: the human virome from bench to bedside","volume":"22","author":"Focosi","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu209","article-title":"Torque teno virus viremia correlates with intensity of maintenance immunosuppression in adult orthotopic liver transplant","volume":"210","author":"Focosi","year":"2014","journal-title":"J Infect Dis"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2013.12.007","article-title":"Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation","volume":"33","author":"G\u00f6rzer","year":"2014","journal-title":"J Hear Lung Transplant"},{"key":"B149","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","article-title":"The Role of mTOR Inhibitors in the Management of Viral Infections: A Review of Current Literature","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation"},{"key":"B150","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.trre.2019.03.004","article-title":"Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation","volume":"33","author":"Rezahosseini","year":"2019","journal-title":"Transplant Rev"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2017.07.001","article-title":"Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients","volume":"94","author":"Albert","year":"2017","journal-title":"J Clin Virol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.09.020","article-title":"Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study","volume":"24","author":"Wohlfarth","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.235","article-title":"The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients","volume":"53","author":"Albert","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.11.002","article-title":"The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT): TTV as a Biomarker in Adult Patients after HSCT","volume":"26","author":"Schmitz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00998","article-title":"Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"11","author":"Pradier","year":"2020","journal-title":"Front Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705094","article-title":"The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation","volume":"36","author":"Giebel","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705648","article-title":"Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: A retrospective study including 148 patients","volume":"39","author":"Heining","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000298","article-title":"The association of CMV with NK-cell reconstitution depends on graft source: Results from BMT CTN-0201 samples","volume":"3","author":"Rashidi","year":"2019","journal-title":"Blood Adv"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113415","article-title":"Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation","volume":"100","author":"Itzykson","year":"2015","journal-title":"Haematologica"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.01.018","article-title":"Early Cytomegalovirus Reactivation Leaves a Specific and Dynamic Imprint on the Reconstituting T Cell Compartment Long-Term after Hematopoietic Stem Cell Transplantation","volume":"20","author":"Lugthart","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-631853","article-title":"CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR\u03b2 repertoire","volume":"125","author":"Suessmuth","year":"2015","journal-title":"Blood"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.4.2645","article-title":"Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly","volume":"176","author":"Hadrup","year":"2006","journal-title":"J Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302053","article-title":"Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig\u2013like Receptor in Patients Transplanted with NKG2C \u2013\/\u2013 Umbilical Cord Blood","volume":"192","author":"Della Chiesa","year":"2014","journal-title":"J Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early Natural Killer Cell Reconstitution Predicts Overall Survival in T Cell\u2013Replete Allogeneic Hematopoietic Stem Cell Transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C + natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.24198","article-title":"Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia","volume":"87","author":"Gim\u00e9nez","year":"2015","journal-title":"J Med Virol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2015.09.003","article-title":"HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire","volume":"76","author":"Lauterbach","year":"2015","journal-title":"Hum Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells article","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat Immunol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.05.025","article-title":"Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transpla","volume":"21","author":"Davis","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401990","article-title":"Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation","volume":"195","author":"Horowitz","year":"2015","journal-title":"J Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02381","article-title":"Impact of CMV Infection on Natural Killer Cell Clonal Repertoire in CMV-Na\u00efve Rhesus Macaques","volume":"10","author":"Truitt","year":"2019","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.07.007","article-title":"Large Granular Lymphocyte Expansion after Allogeneic Hematopoietic Stem Cell Transplant Is Associated with a Cytomegalovirus Reactivation and Shows an Indolent Outcome","volume":"18","author":"Nann-R\u00fctti","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.09.027","article-title":"Gamma Delta T Cell Reconstitution Is Associated with Fewer Infections and Improved Event-Free Survival after Hematopoietic Stem Cell Transplantation for Pediatric Leukemia","volume":"21","author":"Perko","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B174","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","article-title":"Human \u03b3\u03b4 T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection","volume":"18","author":"Ravens","year":"2017","journal-title":"Nat Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12101","article-title":"Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation","volume":"15","author":"Borchers","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-589150","article-title":"CMV promotes recipient T-cell immunity following reduced-intensity T-cell - Depleted HSCT, significantly modulating chimerism status","volume":"125","author":"Sellar","year":"2015","journal-title":"Blood"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: Evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-499830","article-title":"CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: A report from the Acute Leukemia Working Party of EBMT","volume":"122","author":"Schmidt-Hieber","year":"2013","journal-title":"Blood"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic C","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198411000-00004","article-title":"Cytomegalovirus infection associated with and preceding chronic graft\u2013versus\u2013host disease","volume":"38","author":"L\u00f6nnqvist","year":"1984","journal-title":"Transplantation"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-470872","article-title":"HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD41 donor lymphocyte infusion","volume":"122","author":"Stevanovi\u0107","year":"2013","journal-title":"Blood"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12525","article-title":"Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype","volume":"85","author":"Lauterbach","year":"2015","journal-title":"Tissue Antigens"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.04.011","article-title":"Recovery of CMV-Specific CD8+ T Cells and Tregs after Allogeneic Peripheral Blood Stem Cell Transplantation","volume":"17","author":"Pastore","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2018.08.006","article-title":"Human Herpes simplex 1 virus infection of endometrial decidual tissue-derived MSC alters HLA-G expression and immunosuppressive functions","volume":"79","author":"Bortolotti","year":"2018","journal-title":"Hum Immunol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000190102.15300.7d","article-title":"Survival benefit of asymptomatic cytomegalovirus reactivation after HLA-identical allogeneic peripheral blood stem cell transplantation","volume":"81","author":"Kim","year":"2006","journal-title":"Transplantation"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2190-1","article-title":"Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia","volume":"94","author":"Jang","year":"2015","journal-title":"Ann Hematol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005356","article-title":"Prognostic impact of viral reactivations in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation in first complete response","volume":"95","author":"Guenounou","year":"2016","journal-title":"Med (United States)"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-713644","article-title":"Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia","volume":"128","author":"Elmaagacli","year":"2016","journal-title":"Blood"},{"key":"B189","first-page":"1959","article-title":"The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT)","volume-title":"Blood","author":"Grosso","year":"2017"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00389","article-title":"Potential beneficial effects of cytomegalovirus infection after transplantation","volume":"9","author":"Litjens","year":"2018","journal-title":"Front Immunol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18632\/oncotarget.13916","article-title":"Characterization of IFN\u03b3-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705650","article-title":"Long term disease-free survival in acute leukemia patients recovering with increased \u03b3\u03b4 T cells after partially mismatched related donor bone marrow transplantation","volume":"39","author":"Godder","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.374","article-title":"\u03b3\u03b4T cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia","volume":"27","author":"Scheper","year":"2013","journal-title":"Leukemia"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12950","article-title":"Impact of CMV and EBV on immune recovery after allogeneic hematopoietic cell transplantation in children","volume":"38","author":"Pukownik","year":"2018","journal-title":"Anticancer Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8803","article-title":"Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2016.63129","article-title":"Immune recovery and the risk of CMV\/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation","volume":"41","author":"Janeczko","year":"2016","journal-title":"Cent Eur J Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03388.x","article-title":"Skewed T cell receptor repertoire of V\u03b41+ \u03b3\u03b4 T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction","volume":"149","author":"Fujishima","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-255166","article-title":"The Role of V\u03b42-negative \u03b3\u03b4 T Cells During Cytomegalovirus Reactivation in Recipients of Allogeneic Stem Cell Transplantation","volume":"116","author":"Knight","year":"2010","journal-title":"Blood"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000047","article-title":"TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Ahmed","year":"2014","journal-title":"J Immunother"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12260","article-title":"Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival","volume":"92","author":"Auger","year":"2014","journal-title":"Eur J Haematol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702058","article-title":"Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation","volume":"24","author":"Wang","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703657","article-title":"Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients","volume":"30","author":"Wang","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012724","article-title":"Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"2","author":"De Koning","year":"2018","journal-title":"Blood Adv"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.04.016","article-title":"Human Herpes Virus 6 Plasma DNA Positivity after Hematopoietic Stem Cell Transplantation in Children: an Important Risk Factor for Clinical Outcome","volume":"14","author":"Anne de Pagter","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.12.579","article-title":"Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study","volume":"18","author":"Dulery","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.05.012","article-title":"HHV-6 Reactivation and Associated Sequelae after Hematopoietic Cell Transplantation","volume":"18","author":"Zerr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B207","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/ped.13551","article-title":"Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation","volume":"60","author":"Iesato","year":"2018","journal-title":"Pediatr Int"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2013.78","article-title":"Human herpes virus 6 reactivation: Important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT","volume":"48","author":"De Pagter","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.022","article-title":"Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation","volume":"21","author":"Aoki","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2011.07.018","article-title":"The Complex Relationship between Human Herpesvirus 6 and Acute Graft-versus-Host Disease","volume":"18","author":"Pichereau","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.12.021","article-title":"Frequent Detection of Herpes Simplex Virus Antigen in Skin and Peripheral Blood CD34+ Mononuclear Cells from Patients with Graft-versus-Host Disease","volume":"19","author":"Akpek","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2011.02530.x","article-title":"The Impact of Early Viral Infections and Graft-Versus-Host Disease on Immune Reconstitution Following Paediatric Stem Cell Transplantation","volume":"73","author":"Olkinuora","year":"2011","journal-title":"Scand J Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.01.009","article-title":"Viral PCR positivity in stool before allogeneic hematopoietic cell transplantation is strongly associated with acute intestinal graft-versus-host disease","volume":"21","author":"van Montfrans","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 delta32\/delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N Engl J Med"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2011.102","article-title":"Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells","volume":"11","author":"H\u00fctter","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003347","article-title":"Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient","volume":"9","author":"Yukl","year":"2013","journal-title":"PloS Pathog"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0759","article-title":"Mechanisms that contribute to a profound reduction of the HIV-1 reservoir after allogeneic stem cell transplant","volume":"169","author":"Salgado","year":"2018","journal-title":"Ann Intern Med"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001381","article-title":"Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals","volume":"75","author":"Koelsch","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: Report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.04.009","article-title":"HIV-Specific T Cells Generated from Naive T Cells Suppress HIV In Vitro and Recognize Wide Epitope Breadths","volume":"26","author":"Patel","year":"2018","journal-title":"Mol Ther"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nature"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2009.07.020","article-title":"Tax unleashed: Fulminant Tax-positive Adult T-cell Leukemia\/Lymphoma after failed allogeneic stem cell transplantation","volume":"46","author":"Ghez","year":"2009","journal-title":"J Clin Virol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301952","article-title":"HTLV-1 bZIP Factor\u2013Specific CD4 T Cell Responses in Adult T Cell Leukemia\/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"192","author":"Narita","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13948","article-title":"Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy","volume":"110","author":"Kannagi","year":"2019","journal-title":"Cancer Sci"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9729-5","article-title":"Long-term persistence of limited htlv-i tax-specific cytotoxic T cell clones in a patient with adult t cell leukemia\/lymphoma after allogeneic stem cell transplantation","volume":"32","author":"Tanaka","year":"2012","journal-title":"J Clin Immunol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2013.12.016","article-title":"Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02+ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells","volume":"158","author":"Tanaka","year":"2014","journal-title":"Immunol Lett"},{"key":"B229","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/bmt.2010.122","article-title":"Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection","volume":"46","author":"Kawa","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200523","article-title":"T\/NK cell type chronic active Epsteine - Barr virus disease in adults: An underlying condition for Epstein - Barr virus-associated T\/NK-cell lymphoma","volume":"65","author":"Isobe","year":"2012","journal-title":"J Clin Pathol"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-008-9343-8","article-title":"Cardiovascular complications associated with chronic active epstein-barr virus infection","volume":"30","author":"Muneuchi","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20121","article-title":"Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection","volume":"76","author":"Uehara","year":"2004","journal-title":"Am J Hematol"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704074","article-title":"Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting","volume":"32","author":"Yoshiba","year":"2003","journal-title":"Bone Marrow Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.569381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:45:25Z","timestamp":1611103525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.569381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":233,"alternative-id":["10.3389\/fimmu.2020.569381"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.569381","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"article-number":"569381"}}